ArticleThe oncologist2021

Safety and Feasibility of Radiotherapy Plus Camrelizumab for Locally Advanced Esophageal Squamous Cell Carcinoma.

Wencheng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.